The Future of Treating Alcoholism: Framing the Key Research Questions



Similar documents
Causes of Alcohol Abuse and Alcoholism: Biological/Biochemical Perspectives

DSM-IV Alcohol Dependence. Alcohol and Drug Abuse. Screening for Alcohol Risk. DSM-IV Alcohol Abuse

Prevention & Recovery Conference November 28, 29 & 30 Norman, Ok

Source: National Institute on Alcohol Abuse and Alcoholism. Bethesda, Md: NIAAA; NIH Publication No

Addiction Neurobiology

Source: National Institute on Alcohol Abuse and Alcoholism. Bethesda, Md: NIAAA; NIH Publication No

EPIDEMIC 4.6 % OF INDIVIDUALS USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

NEUROPHARMACOLOGY AND ADDICTION CHRISTOPHER M. JONES, PHARMD, MPH

American Society of Addiction Medicine

The Addicted Brain. And what you can do

Brain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair. Michael Fishman, MD Director of Young Adult Program

Alchemy -Neuroscience of Alcoholism

AMPHETAMINE AND COCAINE MECHANISMS AND HAZARDS

What Can Science Contribute to the Treatment of Alcoholism?

Alcohol Overuse and Abuse

Overview. Unit 5: How do our choices change our brains?

12 Steps to Changing Neuropathways. Julie Denton

Addiction Medicine 2014

Drugs and Teens: Current Facts and Recent Trends. Agenda. Adolescent development

Understanding Addiction: The Intersection of Biology and Psychology

The Science of Addiction:

Alcohol and Other Drug Use and Adolescent Brain Development

The Relationship Between the Reward and Stress Systems and How They are Perturbed in Addiction

Identification, treatment and support for individuals with Alcohol & Drug Addiction in the Community

The latest in addiction medicine: What every nurse needs to know

THE BRAIN & DRUGS. Nebraska Training on Substance Abuse Prevention

Substance Addiction. A Chronic Brain Disease

Alcohol Withdrawal Syndrome & CIWA Assessment

The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction

Naltrexone and Alcoholism Treatment Test

The Developing Brain, Adolescence and Vulnerability to Drug Abuse

1. According to recent US national estimates, which of the following substances is associated

ADOLESCENT BRAIN DEVELOPMENT: IMPLICATIONS FOR DRUG USE PREVENTION. Jessie Breyer, B.A. & Ken C. Winters, Ph.D. Center for Substance Abuse Research

substance abuse and addiction are complex phenomena

Seminar/Talk Calendar

ASSIGNMENTS AND GRADING

OVERVIEW OF MEDICATION ASSISTED TREATMENT

Chapter 9: Drug Abuse and Addiction

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )

Denormalizing Tobacco Use in the Behavioral Health Setting

The Brain, Behavior, and Addiction. Objectives. Advances in science have revolutionized our fundamental views of drug abuse and addiction.

Slide 1: Introduction Introduce the purpose of your presentation. Indicate that you will explain how the brain basically works and how and where

Update and Review of Medication Assisted Treatments

Beroendemekanismer- ett beroende som andra?

Relationship Between Stress and Substance Use Disorders: Neurobiologic Interface

WHAT HAPPENS TO OUR BRAIN?

Introduction to Tolerance, Physical Dependence and Withdrawal

Drugs, The Brain, and Behavior

Tolerance and Dependence

Testing Mediators of Topiramate s Effects on Alcohol Use Using Ecological Momentary Assessment Methods

Alcoholism In The Office SCOTT PAIST, III, M. D.

practitioners and physician assistants.advanceweb.com/features/articles/alcohol Abuse.aspx

Neurobiology of Depression in Relation to ECT. PJ Cowen Department of Psychiatry, University of Oxford

Dr. Joseph Frascella

Alcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem. Thomas Kosten MD

Neurobiology and Treatment of Alcohol Dependence. Nebraska MAT Training September 29, 2011

Dual diagnosis: working together

Addictions: Why Don t They Just Quit?

Robert Walker, M.S.W., L.C.S.W., Assistant Professor University of Kentucky

Naltrexone for Opioid & Alcohol Use Disorders

The Limbic System Theory of Addiction

The concept of alcoholism and other drug dependency as

These changes are prominent in individuals with severe disorders, but also occur at the mild or moderate level.

Drug and Alcohol Assessment

Scientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances

The neuroscience of depression: why does it matter? Dr Susan Mizen Exeter

7/29/2013. Pleasure Unwoven: An Adventure in Social Marketing. Choice vs. Disease. Kevin McCauley, MD Texas Behavioral Health Insistute July 2013

Measuring Addiction with DSM Criteria. May 20, 2014 Deborah Hasin, Ph.D. Columbia University

Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania

Alcohol and Health. Alcohol and Mental Illness

Cognitive Behavioral Interventions for Substance Abuse. Overview Presentation TASC Conference University of Cincinnati Corrections Institute

Alcohol Withdrawal. Introduction. Blood Alcohol Concentration. DSM-IV Criteria/Alcohol Abuse. Pharmacologic Effects of Alcohol

LESSON 5.7 WORKBOOK Is addiction a chronic disease?

Medication Assisted Treatment for Alcohol Use Disorders

SC 215 FIGHTING DRUG ADDICTION WITH DRUGS. John Bush April 15, 2013

While the individual patient, rather than his or her disease, is the appropriate

Systematic Review of Treatment for Alcohol Dependence

Alcohol, Stress and the Brain

Alcoholism, like addiction to other drugs, is a chronic, THE POTENTIAL OF NEUROSCIENCE TO INFORM TREATMENT. George F. Koob, Ph.D.

C. Chapman Sledge, MD, FASAM Chief Medical Officer. Nashville, TN

The Neuropharmacology of Drugs of Abuse 3

Harm Reduction Strategies to Address Anxiety and Trauma. Presented by Jodi K. Brightheart, MSW

Transcription:

The Future of Treating Alcoholism: Framing the Key Research Questions Kathleen A. Grant, Ph.D. President, Research Society on Alcoholism A Society of basic, clinical and translation researchers committed to addressing public health concerns related to alcohol abuse and dependence http://www.rsoa.org

RSA lecture series: 2006 Module #1 Module #2 Basics of Alcohol Action: Pharmacodynamics & Etiology of Alcohol Abuse & Alcoholism Metabolism Who becomes alcohol dependent & why? Arthur Cederbaum, Ph.D. Mount Sinai School of Medicine Cardiovascular Effects of Alcohol Sam Zakhari, Ph.D. NIAAA/NIH Effects of Alcohol on the Endocrine System Catherine Rivier, Ph.D. The Salk Institute Alcohol & Stress Stress & Drinking: What is the link? Rajita Sinha, Ph.D. Yale University Neurobiology of Alcoholism: Insights from the dark side of reward neurocircuitry George Koob, Ph.D. The Scripps Research Institute Diagnosis & Assessment of Alcohol Dependence Deborah Hasin, Ph.D. Columbia University Behavioral Treatments for Alcohol Dependence Allen Zweben, Ph.D. Columbia University Medications to Treat Alcoholism: Where WeÕve Been and Where WeÕreGoing Henry Kranzler, M.D. University of Connecticut Kenneth Sher, Ph.D. University of Missouri Alcohol & Genetics: Is your child at risk? Tamara Phillips, Ph.D. Oregon Health and Science University Alcohol-Related Brain Pathology If you drink your brain will shrink! Clive Harper, M.D. University of Sydney Effects of Alcohol on Cognitive Function Sara Jo Nixon, Ph.D. University of Kentucky Fetal Alcohol Spectrum Disorders Edward Riley, Ph.D. San Diego State University Alcohol and Adolescence Linda Spear, Ph.D. Binghamton University College Drinking Mark Goldman, Ph.D. NIAAA/NIH Alcohol Policy Thomas Greenfield, Ph.D. University of California, Berkeley

Key Questions in Alcohol Research Why do some people drink more than others? What are individual differences in drinking quantity and pattern? What contributes to problem drinking and dependence? Prevalence of Past-year DSM-IV Alcohol Dependence by Age - U.S. Drinkers 18 and older 14% 12% 10% 8% 6% 4% 2% 0% 12-17 18-20 21-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 Age Grant and Dawson, NIAAA

Prevalence of DSM-IV Alcohol Use Disorder Diagnoses by sex and age 25 20 Abuse Dependence Percent 15 10 5 0 18-29 30-44 45-64 65+ 18-29 30-44 56-64 65+ Men Women

DSM-IV Dependence Criteria Tolerance* Withdrawal* Using in larger amounts/over a longer time period than intended Persistent desire to cut down/control Great deal of time spent obtaining/using/recovering* Important activities given up/reduced* Continued drinking despite physical/psychological problems that are caused/exacerbated by alcohol* * These criteria are modeled well in animals, whereas terms in red text are human constructs

DSM-IV Abuse Criteria Failure to fulfill major role obligations Recurrent use in physically hazardous situations Recurrent alcohol-related legal problems Continued drinking despite social/interpersonal problems that are caused/exacerbated by alcohol Criteria for alcohol dependence not met

Comprehensive models of why people drink to excess and dependence Pharmacological Vulnerability Affect (mood) Regulation Negative affect regulation ( self-medication ) Positive affect regulation ( reward seeking ) Deviance/Disinhibition

Animal models help address the biological basis of traits found in human alcohol abuse and alcoholism Eventual Binger (16 drinks/day) Eventual non-binger Drinking behavior gulping drinks Brain imaging Sex differences Genetics

Selective breeding for high and low alcohol drinking preference Drinking preferences transfer across environments: An example of salience Water (ml/day) Ethanol intake (g/kg/day) Ethanol ( ml/day) g/kg/day Generations of breeding 2 5 10 15 20 25 30 40 Ethanol concentration

Patterns of drinking show tolerance and attempts to cut down on alcohol consumption Tolerance (increased intake) over 4 months of drinking 800 600 400 200 pellet etoh water One day out of 4 showing volitional cutting down on drinking 16-20 drinks/day 900 800 700 MONKEY 6888 BEC=181 mg/dl (3.42 g/kg) 0 0 2 4 6 8 10 12 14 16 18 20 22 Session Time (hr) 800 600 etoh water pellets 400 200 0 0 2 4 6 8 10 12 14 16 18 20 22 Session Time (hr) 600 500 400 300 200 100 0 0 2 4 6 8 10 12 14 16 18 20 22 Session Time (hr) 16-Jan 17-Jan 18-Jan 19-Jan

Alcohol co-opts normal brain processes that compel behaviors linked to survival Reinforcement Ventral pallidum Nucleus Accumbens Core Prefontal Cortex Impulsivity Ventral Tegmental Area Pleasure/ Positive Reinforcement Ventral Tegmental Area Basolateral amygdala Rats bred to prefer alcohol will inject alcohol directly into the brain (Posterior VTA) Raphe nucleus Hippocampus Extended amydala Central nucleus amydala Bed nucleus stria terminalis Nucleus Accumbens shell Anxiety/ Negative Reinforcement Dopamine Glutamate GABA GABA/CRF/NPY Dopamine/GABA/Opioid 5HT Adapted from Kalivas and Volkow (2005) Am J Psychiatry 162:1403-1413

Potential molecular and neural pathways involved in excessive alcohol drinking have been identified and can be the target of new drug therapies Cholinergic Excitatory Input GLU Excitatory Input CB1-R AMPA NMDA Serotonin Modulatory Input CRF? DOPAMINE (D1, D2) Prefrontal cortex Amygdala Lateral septum Hippocampus GLU Excitatory Input CB1-R Enkephalin Inhibitory Input NIC-R GABA Inhib Input NIC-R Dopamine Neuron GABA Neuron Mu Opioid Receptors GABA Inhibitory feedback GABA Neuron CB1-R REINFORCEMENT Ventral Tegmental Area (VTA) Nucleus Accumbens (nacc)

Genes Contributing to Alcohol-Related Behaviors in both Rodents and Humans Gene a-synuclein BDNF Rodent QTG for alcohol preference (Liang et al., PNAS 2003) BDNF levels in the NAc are lower in P rats than NP rats (Yan et al., Brain Res. 2005) Human associated with alcohol dependence (Bonsch et al., Hum Mol Genet. 2005) association of val66met polymorphism with alcohol dependence & violence in males (Tsai et al., Neurosci Lett. 2005) NMDA NR1 CB1 CCK-AR 5-HTT Mutant mice show attenuated alcohol effects on behavior (Kiefer et al., Biol Psychiatry 2003) KO showed alcohol consumption (Hungund et al., J Neurochem 2003) KO showed alcohol consumption (Miyasaka et al., Alcohol & Alcohol 2005) Alcohol intake in KO mice (Kelai et al., Alcohol Alcohol 2003) the A allele is associated with type I alcohol dependence (Wernicke et al., Biol Psychiatry. 2003) 1359G/A polymorphism confers vulnerability to alcohol withdrawal (Schmidt et al., Drug Alc Dep. 2002) -81A/G polymorphism is Associated with alcohol dependence in a Japanese population (Miyasaka et al., Alcohol & Alcohol 2004) Associated with lower risk of binge drinking (Olsson et al., Mol Psychiatry 2005)

Alcohol has both stimulant and sedative effects: possible risk factor and drug therapy target The stimulant effects of alcohol are at lower doses than the sedative effects Light drinkers and alcohol non-prefering rats do not show stimulation after 2-3 drinks Arousal Index 30 20 10 Light drinkers 2-4 drinks/week N=9 Heavy drinkers 12-24 drinks/week N=9 0 Pre 25 50 75 Pre Time (mins) 25 50 75 DA GABA NMDA Activity (counts above/below saline control) 300 200 100 0-100 -200-300 * * * * P MALES (n=10) * p<0.05 * NP MALES (n=10) * * *.06.12.18.25.50 1.0 1.5.06.12.18.25.50 1.0 1.5 Ethanol, g/kg body weight

Naloxone, over a wide range of doses, decreases alcohol but not water consumption in rats Naloxone Dose (mg/kg)

Stress is likely involved in relapse to drinking after a period of abstinence. Negative Mood-Induced Alcohol Craving Predicts Time to First Drink After Inpatient Treatment

Stress is likely involved in relapse to drinking after a period of abstinence. Animal Models are being developed to help understand this link and suggest possible therapeutic interventions Brain serotonin systems are involved stimulation of serotonin release blockade of serotonin receptors Brain Areas related to anxiety and conflict are involved nucleus accumbens bed nucleus of the stria terminalis

Stress Management is a Key Component of Effective Behavioral Treatments for Alcoholism Cognitive Behavioral Treatment focuses on stress management training Cognitive restructuring, problem solving skills 12-Step Facilitation targets increases social support AA, NA or other peer support programs Enlist family and friends Case management services - housing, employment, medical care New Approaches Gaining Attention: Mindfulness Meditation Desensitization techniques to decrease craving-related distress state. Enhancing attentional/memory abilities to increase prefrontal functioning. Increasing emotional distress tolerance skills.

Conclusion: Research can identify molecular and behavioral aspects of alcoholism for the development of drug and behavioral treatments Brain pathways and candidate genes for: Specific features of alcohol use disorder modeled in animals Transition from voluntary to involuntary drinking Importance of gene-environment interactions Access to alcohol Early childhood experiences Current stressful environments Sex Age relapse